Evaluate the Safety and Potential Efficacy of Human Wharton ' s Jelly-derived Mesenchymal Stem Cells With Charcot-Marie-Tooth Disease Type 1E

Conditions: Charcot-Marie-Tooth Disease, Type 1 Interventions: Biological: human Wharton ' s jelly-derived mesenchymal stem cells Sponsors: Samsung Medical Center Not yet recruiting

https://clinicaltrials.gov/study/NCT06218134

Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials

More News: Charcot-Marie-Tooth Disease | Research | Stem Cell Therapy | Stem Cells